Yatharth Hospital

Vijay Kedia portfolio: Small-cap stock Global Vectra has been part of Vijay Kedia's portfolio since the March 2024 quarter. During Q2 FY26, he acquired 2,59,782 shares of the company via his investment firm Kedia Securities.

Yatharth Hospital's stock has surged over 90% since its IPO last August, prompting Phillip Capital to issue a 'buy' recommendation with a target price of ₹827. The company is expected to achieve strong revenue growth through bed capacity expansion and improved occupancy rates.

SMIFS maintains a ‘buy’ call on Yatharth Hospital with a target price of ₹650, citing growth potential. Stock is trading at a comfortable valuation with significant growth opportunities in the local market. The company also reported strong performance in FY24.

After a 61 percent jump in the stock from its IPO price (listed in August 2023), brokerage house SMIFS sees another 36 percent rise in healthcare company Yatharth Hospitals & Trauma Care Services in the next 12 months.